+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Breast Cancer"

From
Metastatic Breast Cancer Treatment Global Market Report 2024 - Product Thumbnail Image

Metastatic Breast Cancer Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Breast Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Breast Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Advanced Breast Cancer in Premenopausal Women - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Breast Cancer in Premenopausal Women - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
ESR1-Mutated Metastatic Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

ESR1-Mutated Metastatic Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
HER2-Positive Early Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2-Positive Early Breast Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Triple Negative Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Triple Negative Breast Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 230 Pages
  • Global
From
Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Metastatic Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 100 Pages
  • Global
From
Brain Metastasis from Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Brain Metastasis from Breast Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

HER2Negative Metastatic Breast Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Metastatic triple-negative breast cancer (mTNBC) - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic triple-negative breast cancer (mTNBC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Breast Cancer market is a subset of the Women's Health market, focusing on the diagnosis, treatment, and prevention of breast cancer. It includes a range of products and services, from medical devices and pharmaceuticals to patient education and support. Breast cancer is the most common cancer among women worldwide, and the market is driven by the need to improve early detection and treatment outcomes. The Breast Cancer market is highly competitive, with a range of players from large multinationals to small start-ups. Companies in the market include Roche, Novartis, AstraZeneca, Pfizer, Merck, and Johnson & Johnson, as well as smaller players such as Myriad Genetics, Genomic Health, and Natera. Show Less Read more